Associated Papers
Response to olaparib in a PALB2 germline mutated prostate cancer and genetic events associated with resistance.
Horak P et al.
Cold Spring Harbor Molecular Case Studies, 2019
30833416 (PubMed )
Supplement: supp_mcs.a003657_Supplemental_Table_S1.xlsx › primary_tumor_snvs
Select a paper to view details